Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000254392) titled 'A study to determine the effects and safety of starting a glucagon-like peptide-1 receptor agonist before planned cardiac surgery' on March 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Miae Kang - Wellington regional hospital
Condition:
cardiovascular disease
obesity
cardiovascular disease
obesity
Cardiovascular - Other cardiovascular diseases
Diet and Nutrition - Obesity
Intervention:
This study looks at semaglutide a glucagon-like peptide-1 r...